Using MR/PET imaging, researchers from Massachusetts General Hospital in Boston and the Karolinska Institute in Sweden have revealed that widespread neuroinflammation correlates with fatigue levels in patients with fibromyalgia, and may enhance the development of treatment, according to research published online Sept. 14 in Brain, Behavior and Immunity.

AI trained with neuroimaging data may be used to successfully predict outcomes for people at risk of psychosis and depression, according to research published online Sept. 26 in JAMA Psychiatry.

Using MRI, researchers found that brains of infant boys born prematurely are affected differently and more severely than premature infant girls, according to a study published online in the September issue of Nature Pediatric Research.

UCLA researchers have found that the brains of people with schizophrenia are less reactive to social rewards such as positive interactions with others and smiling, according to research published Sept. 5 in Schizophrenia Bulletin.

A “see-through” electroencephalogram (EEG) developed by researchers from Boston Children’s Hospital and Northeastern University in Boston may provide future insight into neurological conditions, according to research published online Sept. 5 in Science Advances.

Researchers using fMRI have found medical marijuana may significantly relieve chronic nerve pain, according to research published online Sept. 5 in Neurology.

Patients with psychosis may benefit from therapeutic effects found to be derived from cannabidiol (CBD), a naturally occurring constituent of cannabis, according to research published Aug. 29 in JAMA Psychiatry.

Brain MRIs have revealed that the anti-inflammatory drug ibudilast may slow down atrophy in patients with progressive multiple sclerosis (MS), according to research published Aug. 30 in the New England Journal of Medicine.